Form D · Biotechnology
Phenomix Sciences LLC
St Paul, MN · CIK 0001757804
Offering snapshot reported Jan 24, 2020 · SEC filing
- Reported sold
- $1.1M Offering amount: $2M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 17, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2020 | Initial | $1,100,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-358919
Convertible promissory note
Source: Form D, filed Jan 24, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andres Acosta | Director, Executive, Promoter |
| Michael Camilleri | Director, Promoter |
| William Ross Higgins | Executive, Promoter |
| Sean Mc Cauley | Director, Promoter |
| Paul Owen | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1000 Westgate Drive Suite 1002
St Paul, MN, 55114
St Paul, MN, 55114